Page 297 - Come vivere più a lungo
P. 297
e colleghi, Japan Sci. Soc. Press, Tokyo/University Park Press, Baltimora,
pp. 177-184, (1979).
BURR R.G., RAJAN K.T., Leukocyte Ascorbic Acid and Pressure Sores in
Paraplegia, British Journal of Nutrition, 28:275-281, (1972).
BUZZARD I.M., MC ROBERTS M.R., DRISCOLL D.L., BOWERINg. J.,
Effect of Dietary Eggs and Ascorbic Acid on Plasma Lipid and Lipoprotein
Cholesterol Levels in Healthy Young. Men, in American Journal of Clinical
Nutrition, 36:94-105, (1982).
CAMERON E., Hyaluronidase and Cancer, Pergamon Press, New York,
(1966).
CAMERON E., Vitamin C, British Journal of Hospital Medicine, 13:511-
514, (1975).
CAMERON E., Biological Function of Ascorbic Acid and the Pathogenesis
of Scurvy, Medical Hypotheses, 2:154-163, (1976).
CAMERON E., BAIRD G., Ascorbic Acid and Dependence on Opiates in
Patients with Advanced Disseminated Cancera, IRCS Lettera all'Editore,
agosto, (1973).
CAMERON E., CAMPBELL A., The Orthomolecular Treatment of Cancer. II.
Clinical Trial of High dose Ascorbic Supplements in Advanced Human Can-
cer, in Chemical-Biological interactions, 9:285-315, (1974).
CAMERON E., CAMPBELL A., JACK T., The Orthomolecular Treatment
of Cancer. III. Reticulum Cell Sarcoma: Double Complete Regression Indu-
ced by High-dose Ascorbic Acid Therapy, in Chemical-Biological Interac-
tions, 11:387-393, (1975).
CAMERON E., PAULING L. Ascorbic Acid and the Glycosaminoglycans:
an Orthomolecular Approach to Cancer and Other Diseases, in Oncology,
27:181-192, (1973).
CAMERON E., PAULING L., The Orthomolecular Treatment of Cancer. I.
The Role of Ascorbic Acid in Host Resistance, in Chemical-Biological Inte-
ractions, 9:273-283, (1974).
CAMERON E., PAULING L., Supplemental Ascorbate in the Supportive
Treatment of Cancer: Prolongation of Survival Times in Terminal Human
Cancer, in Proceedings of the National Academy of Sciences USA, 73: 3685-
3689, (1976).
CAMERON E., PAULING L., Supplemental Ascorbate in the Supportive
Treatment of Cancer: Reevaluation of Prolungation of Survival Times in
Terminal Human Cancer, in Proceedings of the National Academy of Scien-
ces, USA, 75:4538-4542, (1978).